Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Phaos Technology Holdings Cayman EV-to-OCF?
Phaos Technology Holdings CaymanPOAS -6.08%4 EV-to-OCF is -1.61 as of Jul. 26, 2026. GuruFocus rates POAS with a GF Score™ of 4/100. The stock has 5 warning signs investors should review. Among 853 Medical Devices & Instruments companies, Phaos Technology Holdings Cayman ranks better than 66.94% on this metric.
The historical rank and industry rank for Phaos Technology Holdings Cayman's EV-to-OCF or its related term are showing as below:
POAS'
s EV-to-OCF Range Over the Past 10 Years
Min: -29.04 Med: -9.19 Max: -1.08
Current: -1.61
During the past 3 years, the highest EV-to-OCF of Phaos Technology Holdings Cayman was -1.08. The lowest was -29.04. And the median was -9.19.
POAS's EV-to-OCF is ranked better than 66.94% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 7.78
vs POAS: -1.61
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Phaos Technology Holdings Cayman's PE Ratio (TTM) for today is calculated as:
Phaos Technology Holdings Cayman's share price for today is $0.2208.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Phaos Technology Holdings Cayman's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Oct. 2025 was $-0.264.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Phaos Technology Holdings Cayman EV-to-OCF Related Terms
Phaos Technology Holdings Cayman EV-to-OCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Phaos Technology Holdings Cayman's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Phaos Technology Holdings Cayman EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Phaos Technology Holdings Cayman's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Phaos Technology Holdings Cayman's EV-to-OCF falls into.
Phaos Technology Holdings Cayman's current Enterprise Value is $3.71 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Phaos Technology Holdings Cayman's Cash Flow from Operations for the trailing twelve months (TTM) ended in Oct. 2025 was $-2.30 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Phaos Technology Holdings Cayman (POAS) has a EV-to-OCF of -1.61 as of Jul. 26, 2026. According to the industry distribution chart, Phaos Technology Holdings Cayman ranks #282 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 33.1%.
Is Phaos Technology Holdings Cayman's EV-to-OCF too high?
Phaos Technology Holdings Cayman's current EV-to-OCF is -1.61. Based on the distribution chart, Phaos Technology Holdings Cayman ranks #282 out of 853 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Phaos Technology Holdings Cayman has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Phaos Technology Holdings Cayman's EV-to-OCF compare to WOK and ITOC?
According to the Medical Devices & Instruments industry distribution chart, Phaos Technology Holdings Cayman ranks #282 out of 853 companies for EV-to-OCF. This puts Phaos Technology Holdings Cayman in the upper half of its industry. The industry median EV-to-OCF is 7.78. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.78, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Phaos Technology Holdings Cayman's current EV-to-OCF is -1.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phaos Technology Holdings Cayman stock overvalued right now?
Phaos Technology Holdings Cayman (POAS) has a current EV-to-OCF of -1.61. The current EV-to-OCF is -1.61. Phaos Technology Holdings Cayman's overall GF Score™ is 4/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Phaos Technology Holdings Cayman (POAS), the current EV-to-OCF is -1.61 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Phaos Technology Holdings Cayman Business Description
Phaos Technology Holdings Cayman Ltd is an investment holding company incorporated in the Cayman Islands. Through its subsidiaries, the Company engages in the research, development, manufacturing, and commercialization of advanced optical technologies and products. Leveraging its patented microsphere technology, Phaos enhances the magnification of traditional optical microscopes, enabling visualization beyond the 200nm optical limit at a commercially viable working distance. The Company offers advanced microscopy equipment and parts, along with AI-powered software solutions that complement its hardware to deliver fully integrated microscopy systems. Its technologies serve diverse sectors, including manufacturing, biomedical, and research.
4GF Score
Get the complete analysis for POAS
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
POAS has been successfully added to your 
